Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent
收藏Protein Data Bank Japan2023-10-11 更新2026-03-21 收录
下载链接：
https://pdbj.org/mine/summary/6p5p
下载链接
链接失效反馈官方服务：
资源简介：
Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent Descriptor: 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one, Rho-associated protein kinase 2 Authors: Hoffman, I.D, Skene, R.J. Deposit date: 2019-05-30 Release date: 2020-01-15 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (3.3 Å) Cite: Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent. J.Med.Chem., 63, 2020
创建时间：
2019-05-30
